253 related articles for article (PubMed ID: 30947296)
41. 2B4 (CD244)-CD48 interactions provide a novel MHC class I-independent system for NK-cell self-tolerance in mice.
McNerney ME; Guzior D; Kumar V
Blood; 2005 Aug; 106(4):1337-40. PubMed ID: 15870174
[TBL] [Abstract][Full Text] [Related]
42. 2B4 (CD244)-mediated activation of cytotoxicity and IFN-gamma release in human NK cells involves distinct pathways.
Chuang SS; Kumaresan PR; Mathew PA
J Immunol; 2001 Dec; 167(11):6210-6. PubMed ID: 11714782
[TBL] [Abstract][Full Text] [Related]
43. Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function.
Vacca P; Pietra G; Falco M; Romeo E; Bottino C; Bellora F; Prefumo F; Fulcheri E; Venturini PL; Costa M; Moretta A; Moretta L; Mingari MC
Blood; 2006 Dec; 108(13):4078-85. PubMed ID: 16931625
[TBL] [Abstract][Full Text] [Related]
44. NKG2D ligation relieves 2B4-mediated NK-cell self-tolerance in mice.
Lee JE; Lim SA; Kim TJ; Kim K; Ng J; Kim YH; Jang IJ; Oh SB; Lee JC; Yee C; Kumar V; Lee KM
Eur J Immunol; 2014 Jun; 44(6):1802-13. PubMed ID: 24610736
[TBL] [Abstract][Full Text] [Related]
45. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48.
Brown MH; Boles K; van der Merwe PA; Kumar V; Mathew PA; Barclay AN
J Exp Med; 1998 Dec; 188(11):2083-90. PubMed ID: 9841922
[TBL] [Abstract][Full Text] [Related]
46. Molecular characterization of the rat NK cell receptor 2B4.
Kumaresan PR; Stepp SE; Verrett PC; Chuang SS; Boles KS; Lai WC; Ryan JC; Bennett M; Kumar V; Mathew PA
Mol Immunol; 2000; 37(12-13):735-44. PubMed ID: 11275258
[TBL] [Abstract][Full Text] [Related]
47. 2B4 and CD48: A powerful couple of the immune system.
Pahima H; Puzzovio PG; Levi-Schaffer F
Clin Immunol; 2019 Jul; 204():64-68. PubMed ID: 30366105
[TBL] [Abstract][Full Text] [Related]
48. NMR structure of the natural killer cell receptor 2B4 (CD244): implications for ligand recognition.
Ames JB; Vyas V; Lusin JD; Mariuzza R
Biochemistry; 2005 May; 44(17):6416-23. PubMed ID: 15850375
[TBL] [Abstract][Full Text] [Related]
49. Molecular characterization of a novel human natural killer cell receptor homologous to mouse 2B4.
Boles KS; Nakajima H; Colonna M; Chuang SS; Stepp SE; Bennett M; Kumar V; Mathew PA
Tissue Antigens; 1999 Jul; 54(1):27-34. PubMed ID: 10458320
[TBL] [Abstract][Full Text] [Related]
50. 2B4 (CD244) is a non-MHC binding receptor with multiple functions on natural killer cells and CD8+ T cells.
McNerney ME; Lee KM; Kumar V
Mol Immunol; 2005 Feb; 42(4):489-94. PubMed ID: 15607804
[TBL] [Abstract][Full Text] [Related]
51. Molecular basis of the dual functions of 2B4 (CD244).
Chlewicki LK; Velikovsky CA; Balakrishnan V; Mariuzza RA; Kumar V
J Immunol; 2008 Jun; 180(12):8159-67. PubMed ID: 18523281
[TBL] [Abstract][Full Text] [Related]
52. 2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism.
Nakajima H; Colonna M
Hum Immunol; 2000 Jan; 61(1):39-43. PubMed ID: 10658976
[TBL] [Abstract][Full Text] [Related]
53. Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ.
Galitska G; Coscia A; Forni D; Steinbrueck L; De Meo S; Biolatti M; De Andrea M; Cagliani R; Leone A; Bertino E; Schulz T; Santoni A; Landolfo S; Sironi M; Cerboni C; Dell'Oste V
Front Immunol; 2021; 12():532484. PubMed ID: 33897679
[TBL] [Abstract][Full Text] [Related]
54. Human natural killer cell receptor 2B4 (CD244) down-regulates its own expression by reduced promoter activity at an Ets element.
Mathew SO; Vaidya SV; Kim JR; Mathew PA
Biochem Biophys Res Commun; 2007 Apr; 355(2):483-7. PubMed ID: 17300754
[TBL] [Abstract][Full Text] [Related]
55. HTLV-1 specific CD8+ T cell function augmented by blockade of 2B4/CD48 interaction in HTLV-1 infection.
Ezinne CC; Yoshimitsu M; White Y; Arima N
PLoS One; 2014; 9(2):e87631. PubMed ID: 24505299
[TBL] [Abstract][Full Text] [Related]
56. TGF-β regulated leukemia cell susceptibility against NK targeting through the down-regulation of the CD48 expression.
Huang CH; Liao YJ; Chiou TJ; Huang HT; Lin YH; Twu YC
Immunobiology; 2019 Sep; 224(5):649-658. PubMed ID: 31421859
[TBL] [Abstract][Full Text] [Related]
57. 2B4 (CD244) signaling by recombinant antigen-specific chimeric receptors costimulates natural killer cell activation to leukemia and neuroblastoma cells.
Altvater B; Landmeier S; Pscherer S; Temme J; Schweer K; Kailayangiri S; Campana D; Juergens H; Pule M; Rossig C
Clin Cancer Res; 2009 Aug; 15(15):4857-66. PubMed ID: 19638467
[TBL] [Abstract][Full Text] [Related]
58. Defective NK cell activation in X-linked lymphoproliferative disease.
Benoit L; Wang X; Pabst HF; Dutz J; Tan R
J Immunol; 2000 Oct; 165(7):3549-53. PubMed ID: 11034354
[TBL] [Abstract][Full Text] [Related]
59. Human innate lymphoid cell precursors express CD48 that modulates ILC differentiation through 2B4 signaling.
Tufa DM; Yingst AM; Trahan GD; Shank T; Jones D; Shim S; Lake J; Winkler K; Cobb L; Woods R; Jones K; Verneris MR
Sci Immunol; 2020 Nov; 5(53):. PubMed ID: 33219153
[TBL] [Abstract][Full Text] [Related]
60. 2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes.
Boles KS; Stepp SE; Bennett M; Kumar V; Mathew PA
Immunol Rev; 2001 Jun; 181():234-49. PubMed ID: 11513145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
